Hillsdale Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-39,279
| Closed | -$1.72M | – | 579 |
|
|
2024
Q1 | $1.72M | Sell |
39,279
-57,074
| -59% | -$2.51M | 0.14% | 188 |
|
|
2023
Q4 | $5.96M | Sell |
96,353
-195
| -0.2% | -$12.1K | 0.49% | 34 |
|
|
2023
Q3 | $4.44M | Sell |
96,548
-3,660
| -4% | -$168K | 0.41% | 70 |
|
|
2023
Q2 | $5.76M | Sell |
100,208
-54,830
| -35% | -$3.15M | 0.53% | 43 |
|
|
2023
Q1 | $5.81M | Sell |
155,038
-17,200
| -10% | -$645K | 0.5% | 54 |
|
|
2022
Q4 | $4.83M | Sell |
172,238
-25,500
| -13% | -$715K | 0.41% | 77 |
|
|
2022
Q3 | $5.56M | Hold |
197,738
| – | – | 0.5% | 52 |
|
|
2022
Q2 | $6.88M | Sell |
197,738
-36,600
| -16% | -$1.27M | 0.55% | 34 |
|
|
2022
Q1 | $8.41M | Buy |
+234,338
| New | +$8.41M | 0.54% | 32 |
|
|
2019
Q3 | – | Sell |
-33,800
| Closed | -$714K | – | 609 |
|
|
2019
Q2 | $714K | Buy |
33,800
+6,800
| +25% | +$144K | 0.07% | 267 |
|
|
2019
Q1 | $552K | Buy |
27,000
+4,400
| +19% | +$90K | 0.05% | 273 |
|
|
2018
Q4 | $450K | Buy |
+22,600
| New | +$450K | 0.05% | 269 |
|